Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD. - Wikidata - awgldk - TriplyDB

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

http://www.wikidata.org/entity/Q33251988

about

Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies A Chinese Creutzfeldt-Jakob disease patient with E196K mutation in PRNP Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years Proteomic and bioinformatic analyses of spinal cord injury‑induced skeletal muscle atrophy in rats Infectious disease - developments in the field of Creutzfeldt-Jakob disease A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.EEG abnormalities in poikilothermia suggesting Creutzfeldt-Jakob disease.The Levels of Tau Isoforms Containing Exon-2 and Exon-10 Segments Increased in the Cerebrospinal Fluids of the Patients with Sporadic Creutzfeldt-Jakob Disease.Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease Diagnostic.

P2860

Q27345459-A03025D1-9D2C-4E90-BE55-6B301C3FBCEE Q33649832-7C276921-3A55-4A89-9728-CF8451C1BE6E Q33728522-6D0EF2D4-8462-4840-A788-5324E058A97B Q33847248-BFB1CB6E-6BAD-402A-BC61-85D8970215A8 Q34059789-991FEE5E-1C5B-48CD-AB6C-59E2845BF8E0 Q34901990-6E09D650-5C7C-49C8-8A9C-5447F4CA1D2E Q35194934-F4127F77-AC61-4487-B4E5-E4FEF4E8E4C9 Q36315347-641B878A-A683-4EC7-88EE-5B377DE2C4ED Q37032252-1699A2A0-632C-4D70-B6D5-63A995D9C777 Q37035561-B71E87A2-7088-4090-B615-3B6670070B9F Q39447075-512F7022-402A-44F2-97C6-A3976D5931D8 Q40381326-548B9EED-C3C6-4898-9348-6ED50E5E3AD5 Q40721465-6E27ED76-2C98-4C6E-A1FB-A1005D3E42DF Q40969376-F67EE133-8AFB-4DB2-B0C7-DD3603F76D8C

P2860

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

http://www.wikidata.org/entity/Q33251988

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@ast

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@en

type

label

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@ast

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@en

prefLabel

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@ast

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@en

P1433

Q33251988-7FC6A4E8-2389-4BC2-9B99-4C638AA1426D

P1476

Q33251988-0141DFA1-F3F2-491E-AAA9-C93265619CBC

P2093

Q33251988-09FF8A5D-2815-4188-B0C7-D74E67734633

Q33251988-2CB0FD84-8E70-473C-8AB3-EDD2F03648EC

Q33251988-58D105BD-A382-4349-9F12-FAAA3A1A0F9E

Q33251988-5D30DA85-D603-4ACD-A188-B7F6D83D62BB

Q33251988-9831976C-718B-44D2-9284-EAA6DEA5459D

Q33251988-BA32F288-6480-4E1D-B4F3-AB1DB7C51854

Q33251988-D0DDD26C-F144-40A1-82CA-B3B89DB38323

Q33251988-FB9DEA29-0115-48A2-9616-769C0C0241F7

Q33251988-FDCE8A5F-B48E-4B3C-BFE1-CD0EA6A37C4B

P2860

Q33251988-3966226A-B09A-46D7-A3F2-CF993E0506C8

Q33251988-4509AE39-7127-4C17-AA16-1C8B4F9C0864

Q33251988-4D533915-3552-4EC3-8DF0-FE77AA2CE405

Q33251988-59E43642-6169-4350-8AEA-8699A43731F7

Q33251988-80807E22-27F6-4161-8810-FCE9C33A5B5C

Q33251988-8EFF7DDD-0EB9-4F88-B7A8-36C9C626655D

Q33251988-9BCE287E-3F75-43F5-BDCE-97D49C3676A4

Q33251988-9EDDBA0F-5225-41AF-9B96-52FD87181282

Q33251988-A23BCFF9-D60A-465A-9669-B4A9B5AF681E

Q33251988-CBE1FDB8-CDC2-4920-92C7-239B7BC86812

P2888

Q33251988-C44282FA-F49F-4886-9DBE-D834B4CD7C98

P304

Q33251988-132151A3-EBBE-4E91-9E1E-2C18A2B08B25

P31

Q33251988-D56908FD-75A8-49FA-93E0-AA77AAA3D66A

P356

Q33251988-82A117D5-77A9-4BE7-AD9E-80D3EDCE074E

P433

Q33251988-B5FC27AD-0E9D-43BD-A0AA-26F953187E97

P478

Q33251988-6A73AF99-92A6-4701-A654-FDFC6E743B85

P50

Q33251988-0092D651-62ED-4843-87B8-E4AB67AF809D

Q33251988-CAFD40C5-1E84-4DDB-8137-D98D3051C2F4

P577

Q33251988-AE7B6F2D-F644-4876-8C1E-C6E103CB162F

P5875

Q33251988-3B87B3DD-4388-48B9-87FF-B76246A6EE12

P6179

Q33251988-F6148B3C-4734-479F-A8D6-D75C481EE8EF

P698

Q33251988-C07F4077-ACBD-4505-AFDB-3A07DF60CE0A

P932

Q33251988-D9A86D86-E1A0-4054-91C9-F1F8066A8FFA

P356

P1433

P1476

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD.

@en

P2093

Adolfo Jiménez-Huete

http://www.w3.org/2001/XMLSchema#string

Alberto Rábano

http://www.w3.org/2001/XMLSchema#string

Carmen Albo

http://www.w3.org/2001/XMLSchema#string

Jesús de Pedro-Cuesta

http://www.w3.org/2001/XMLSchema#string

Laura Cerrato

http://www.w3.org/2001/XMLSchema#string

Luz Vega

http://www.w3.org/2001/XMLSchema#string

Maríajosé Sierra-Moros

http://www.w3.org/2001/XMLSchema#string

Natividad Cuadrado-Corrales

http://www.w3.org/2001/XMLSchema#string

Rafael Hortigüela

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests.

Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease.

CSF detection of the 14-3-3 protein in unselected patients with dementia.

Sporadic Creutzfeldt-Jakob disease in a young Dutch valine homozygote: atypical molecular phenotype.

14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.

Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.

14-3-3 protein in the CSF of patients with rapidly progressive dementia.

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders

P2888

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2377-6-25

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Hortigüela

P577

2006-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6914948

http://www.w3.org/2001/XMLSchema#string

P6179

1020868879

http://www.w3.org/2001/XMLSchema#string

P698

16872484

http://www.w3.org/2001/XMLSchema#string

P932

1570138

http://www.w3.org/2001/XMLSchema#string